Tag: "nrp104" at medical news

Abuse liability study results of lisdexamfetamine dimesylate (NRP104) presented at CPDD

... New River Pharmaceuticals Inc. (NASDAQ: NRPH) designed lisdexamfetamine dimesylate as an inacti...

NRP104 significantly reduced symptoms of attention deficit hyperactivity disorder in children

TorontoV Shire plc (Nasdaq: SHPGY, LSE: SHP, TSX: SHQ) and New River Pharmaceuticals Inc. (Nasdaq: NRPH) announced today that treatment with the investigational drug, lisdexamfetamine dimesylate (NRP104), demonstrated statistically significant reduction in the symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in children aged 6 to 12 years according to the results of a phase III trial p...
(Date:4/16/2014)... of the Physical Biosciences Division of Lawrence Berkeley ... is recognized as a leading authority on the ... and their application to systems and synthetic biology, ... the 2013 Ernest Orlando Lawrence Award by U.S. ... the Department of Energy (DOE),s highest scientific honor, ...
(Date:4/16/2014)... or to conquer the world? Surprisingly, bacteria also ... in Munich have now shown how these organisms ... , The bacterium Bacillus subtilis is ... on agar surfaces by means of flagella. Alternatively, ... the bacteria proliferate most effectively in this stationary ...
(Date:4/16/2014)... Prechtl, Leo Heim and their colleagues at the University ... method of generating hydrogen using water and formaldehyde. The ... when it comes to fuel cell technologies. The results ... using water and formaldehyde", have recently been published in ... applications, the new approach can be used to recycle ...
Breaking Biology News(10 mins):Berkeley Lab's Adam Arkin wins 2013 Lawrence Award 2Berkeley Lab's Adam Arkin wins 2013 Lawrence Award 3Theoretical biophysics: Adventurous bacteria 2
Other Tags
coochydadvisualizationsemenliposomedepositsusuallyintermittentlymichelleunitesisterleanerviablepylorihelicobacterradcare